Tradestie Institutional Equity Comparison Engine
HQL vs THQ โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
HQL Overall Edge
HQL Captures Institutional Edge (1โ0 Pillars ยท 1โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to abrdn Life Sciences Investors (HQL) driven by superior Momentum & Technical. Fundamentally, HQL trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus THQ at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, HQL sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against THQ sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
HQL N/M vs THQ N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner
HQL
1Y +5.9% vs +3.4% ยท 52W Pos 30% vs 62%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
HQL
NYSE
abrdn Life Sciences Investors
Institutional Equity
$17.76
-2.84% 1D
Market Cap
$455.0M
1M Return
+5.84%
1Y Return
+5.9%
Forward P/E
N/M
Unified AI Score
46.0 / 100
HOLD
Tech 48.0
Fund 52.0
Flow 50.0
Mom 60.0
THQ
NYSE
abrdn Healthcare Opportunities Fund
Institutional Equity
$18.82
-1.16% 1D
Market Cap
$734.5M
1M Return
+4.96%
1Y Return
+3.41%
Forward P/E
N/M
Unified AI Score
45.8 / 100
HOLD
Tech 39.0
Fund 38.0
Flow 50.0
Mom 22.3
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
HQL +5.9%
THQ +3.41%
Spread: +2.49 pp (HQL Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
HQL TTM Op. Margin: N/A
THQ TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on HQL vs THQ. Trailing 12-month operating profitability (HQL N/A vs THQ N/A) and valuation multiples (HQL N/M vs THQ N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | HQL | THQ | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $455.0M | $734.5M | Larger Scale | THQ |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | N/A | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | N/A | N/A | Higher Margin | Tie |
| Net Profit Margin Profitability | N/A | N/A | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | N/A | N/A | Higher ROE | Tie |
| 52-Week Range Position Momentum | 30% ($16โ$23) | 62% ($16โ$20) | Stronger Trend | THQ |
| Beta / 30D Volatility Risk Regime | 0.90ฮฒ ยท 39% Vol | 0.52ฮฒ ยท 23% Vol | Lower Realized Risk | THQ |
| Unified Institutional Score Composite Signal | 46.0 / 100 (HOLD) | 45.8 / 100 (HOLD) | Higher Composite | HQL |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full HQL vs THQ Buy Guide
HQL
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
THQ
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither HQL nor THQ registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.